Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Mutations in the HFE gene can be associated with increased lung disease severity in cystic fibrosis.

Smith DJ, Klein K, Hartel G, Wainwright CE, Bell SC, Anderson GJ, Reid DW.

Gene. 2019 Jan 30;683:12-17. doi: 10.1016/j.gene.2018.10.002. Epub 2018 Oct 3.

PMID:
30291871
2.

Aspergillus and progression of lung disease in children with cystic fibrosis.

Harun SN, Wainwright CE, Grimwood K, Hennig S; Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group.

Thorax. 2018 Oct 1. pii: thoraxjnl-2018-211550. doi: 10.1136/thoraxjnl-2018-211550. [Epub ahead of print]

PMID:
30275132
3.

Secrets of intercontinental flight.

Fuller RA, Wainwright CE.

Nat Ecol Evol. 2018 Oct;2(10):1523-1524. doi: 10.1038/s41559-018-0693-1. No abstract available.

PMID:
30228342
4.

Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.

Martin LW, Robson CL, Watts AM, Gray AR, Wainwright CE, Bell SC, Ramsay KA, Kidd TJ, Reid DW, Brockway B, Lamont IL.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01789-18. doi: 10.1128/AAC.01789-18. Print 2018 Nov.

PMID:
30201819
5.

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis.

Tarique AA, Sly PD, Cardenas DG, Luo L, Stow JL, Bell SC, Wainwright CE, Fantino E.

J Cyst Fibros. 2018 Aug 31. pii: S1569-1993(18)30744-6. doi: 10.1016/j.jcf.2018.07.012. [Epub ahead of print]

PMID:
30177416
6.

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1.

McColley SA, Konstan MW, Ramsey BW, Stuart Elborn J, Boyle MP, Wainwright CE, Waltz D, Vera-Llonch M, Marigowda G, Jiang JG, Rubin JL.

J Cyst Fibros. 2018 Aug 23. pii: S1569-1993(18)30719-7. doi: 10.1016/j.jcf.2018.07.011. [Epub ahead of print]

7.

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study.

Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group.

Lancet Respir Med. 2018 Jul;6(7):545-553. doi: 10.1016/S2213-2600(18)30202-9. Epub 2018 Jun 7. Erratum in: Lancet Respir Med. 2018 Jul;6(7):e35.

PMID:
29886024
8.

Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei.

Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Kidd TJ, Cheney J, Ballard EL, O'Rourke P, Jabbour N, Wainwright CE, Knibbs LD, Sly PD, Morawska L, Bell SC.

Thorax. 2018 Apr 7. pii: thoraxjnl-2018-211567. doi: 10.1136/thoraxjnl-2018-211567. [Epub ahead of print]

PMID:
29627800
9.

Ongoing changes in migration phenology and winter residency at Bracken Bat Cave.

Stepanian PM, Wainwright CE.

Glob Chang Biol. 2018 Jul;24(7):3266-3275. doi: 10.1111/gcb.14051. Epub 2018 Feb 14.

PMID:
29442413
10.

Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic Fibrosis.

Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Jabbour N, Ballard E, O'Rourke P, Kidd TJ, Wainwright CE, Knibbs LD, Sly PD, Morawska L, Bell SC.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):348-355. doi: 10.1164/rccm.201707-1457OC.

PMID:
28930641
11.

Extending bioacoustic monitoring of birds aloft through flight call localization with a three-dimensional microphone array.

Stepanian PM, Horton KG, Hille DC, Wainwright CE, Chilson PB, Kelly JF.

Ecol Evol. 2016 Sep 12;6(19):7039-7046. doi: 10.1002/ece3.2447. eCollection 2016 Oct.

12.

The movement of small insects in the convective boundary layer: linking patterns to processes.

Wainwright CE, Stepanian PM, Reynolds DR, Reynolds AM.

Sci Rep. 2017 Jul 14;7(1):5438. doi: 10.1038/s41598-017-04503-0.

13.

Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.

Flume PA, Wainwright CE, Elizabeth Tullis D, Rodriguez S, Niknian M, Higgins M, Davies JC, Wagener JS.

J Cyst Fibros. 2018 Jan;17(1):83-88. doi: 10.1016/j.jcf.2017.06.002. Epub 2017 Jun 24.

14.

Preserving Lung Function: The Holy Grail in Managing Cystic Fibrosis.

Sly PD, Wainwright CE.

Ann Am Thorac Soc. 2017 Jun;14(6):833-835. doi: 10.1513/AnnalsATS.201703-254ED. No abstract available.

PMID:
28570157
15.

New treatments targeting the basic defects in cystic fibrosis.

Fajac I, Wainwright CE.

Presse Med. 2017 Jun;46(6 Pt 2):e165-e175. doi: 10.1016/j.lpm.2017.01.024. Epub 2017 May 26. Review.

PMID:
28554723
16.

Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep.

Jee AS, Corte TJ, Wort SJ, Eves ND, Wainwright CE, Piper A.

Respirology. 2017 Jul;22(5):1022-1034. doi: 10.1111/resp.13080. Epub 2017 May 25. Review. No abstract available.

PMID:
28544189
17.

CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.

Tarique AA, Sly PD, Holt PG, Bosco A, Ware RS, Logan J, Bell SC, Wainwright CE, Fantino E.

J Cyst Fibros. 2017 Jul;16(4):475-482. doi: 10.1016/j.jcf.2017.03.011. Epub 2017 Apr 17.

PMID:
28428011
18.

Sources and dynamics of fluorescent particles in hospitals.

Pereira ML, Knibbs LD, He C, Grzybowski P, Johnson GR, Huffman JA, Bell SC, Wainwright CE, Matte DL, Dominski FH, Andrade A, Morawska L.

Indoor Air. 2017 Sep;27(5):988-1000. doi: 10.1111/ina.12380. Epub 2017 May 5.

PMID:
28303606
19.

Inhaled Corticosteroids and Respiratory Infections in Children With Asthma: A Meta-analysis.

Cazeiro C, Silva C, Mayer S, Mariany V, Wainwright CE, Zhang L.

Pediatrics. 2017 Mar;139(3). pii: e20163271. doi: 10.1542/peds.2016-3271. Review.

20.

Targeted therapy for chronic respiratory disease: a new paradigm.

Gibson PG, Peters MJ, Wainwright CE.

Med J Aust. 2017 Feb 20;206(3):136-140. Review.

PMID:
28208047

Supplemental Content

Loading ...
Support Center